Skip to content

The Effect of a Mediterranean Diet Intervention on Cancer-related Fatigue and Mitochondrial Function During Chemotherapy

Diet And Nutrition In CAncer (The DANICA Study): The Effect of a Mediterranean Diet Intervention on Cancer-related Fatigue and Mitochondrial Function During Chemotherapy

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04534738
Acronym
DANICA
Enrollment
33
Registered
2020-09-01
Start date
2020-11-14
Completion date
2022-02-20
Last updated
2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

nutrition, diet

Brief summary

This study will assess the feasibility of delivering an 8-week Mediterranean Diet intervention as well as the intervention's preliminary efficacy on cancer-related fatigue among patients undergoing chemotherapy, compared to usual care. In the first 4 weeks of the intervention, we will provide the participants with food and educate them on the principles and components of the Mediterranean Diet, while in the second 4 weeks participants will prepare their own food. In addition, we will evaluate changes in metabolism and mitochondrial function during 4 weeks of chemotherapy and determine how adherence to a Mediterranean diet modulates these changes during these 4 weeks. The hypothesis is that the intervention will promote adherence to the Mediterranean Diet. The second hypothesis is that adherence will be associated with alleviation of fatigue and improvements in metabolic and mitochondrial function.

Interventions

BEHAVIORALMediterranean Diet

The Mediterranean Diet is high in fruit, vegetables, legumes, nuts and seeds, whole grains, and olive oil; moderate in seafood, dairy products (e.g., cheese and yogurt but not whole milk or butter), eggs, poultry, and red wine with meals; and low consumption of sweet desserts, red meat, and highly processed foods.

Sponsors

University of Rochester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(Participants must…): * Have a diagnosis of cancer, * Be scheduled to receive chemotherapy and have at least 6 weeks remaining, * Be able to speak English, * Be willing to adhere to study procedures, and * Be able to provide written informed consent.

Exclusion criteria

(Participants must not…): * Be on enteral or parenteral nutrition, * Be pregnant, * Have distant metastases, * Have a brain tumor, * Have any plan to get radiation to the head, * Have specific dietary needs that a Mediterranean diet cannot meet (e.g., allergies to nuts, gluten intolerance), or already be following the Mediterranean diet (i.e., have a score ≥10 on a modified 14-item Mediterranean Diet questionnaire).

Design outcomes

Primary

MeasureTime frameDescription
The Number of Patients Who Enrolled Completed the Study.8 weeksTo assess feasibility of the study, we will report what percentage of patients who enrolled completed the study.
Scores From the 14-item Mediterranean Diet Questionnaire8 weeksIn order to assess adherence to the diet, we will report scores from the 14-item Mediterranean Diet questionnaire at 8 weeks. Scores range from 0 to 14 points. A higher score indicates greater adherence to the Mediterranean Diet.

Secondary

MeasureTime frameDescription
The Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire8 weeksFatigue will be measured using the Functional Assessment of Chronic Illness-Fatigue (FACIT-F). This is a 40-item questionnaire in which a higher score indicates greater well-being. Scores range from 0-160.
The Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire, Fatigue Subscale8 weeksFatigue will be measured using the Functional Assessment of Chronic Illness-Fatigue (FACIT-F), fatigue subscale. This is a 13-item subscale of the FACIT-F questionnaire in which a higher score indicates less fatigue. Scores range from 0-52.

Countries

United States

Participant flow

Participants by arm

ArmCount
Mediterranean Diet
Participants in the Mediterranean Diet arm are asked to follow a Mediterranean Diet for 8 weeks. The diet is ad libitum. A combination of fresh, frozen, and shelf-stable meals are provided for the first 4 weeks. Also during the first 4 weeks, participants receive an education session to discuss how to effectively implement a Mediterranean Diet into their daily routine. Mediterranean Diet: The Mediterranean Diet is high in fruit, vegetables, legumes, nuts and seeds, whole grains, and olive oil; moderate in seafood, dairy products (e.g., cheese and yogurt but not whole milk or butter), eggs, poultry, and red wine with meals; and low consumption of sweet desserts, red meat, and highly processed foods.
23
Usual Care
Participants in the usual care are will complete all the same study assessments as those in the intervention group. They will not receive any specific dietary advice, but they will be permitted to seek dietary advice outside the study. Data from this group are indispensable in understanding the nutritional habits and preferences of patients undergoing chemotherapy, and these data will be used to optimize nutritional interventions in future studies. At the end of the 8-week intervention, the participants in the usual care group will be provided the intervention materials gratis, including one-week of Mediterranean Diet food and education materials.
10
Total33

Baseline characteristics

CharacteristicMediterranean DietTotalUsual Care
Age, Continuous51.7 years
STANDARD_DEVIATION 14.2
51.0 years
STANDARD_DEVIATION 14.6
49.2 years
STANDARD_DEVIATION 16.3
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
23 Participants33 Participants10 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants2 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants2 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
20 Participants29 Participants9 Participants
Region of Enrollment
United States
23 participants33 participants10 participants
Sex: Female, Male
Female
21 Participants31 Participants10 Participants
Sex: Female, Male
Male
2 Participants2 Participants0 Participants
Type of cancer
Breast cancer
20 Participants30 Participants10 Participants
Type of cancer
Other
3 Participants3 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 230 / 10
other
Total, other adverse events
0 / 230 / 10
serious
Total, serious adverse events
6 / 232 / 10

Outcome results

Primary

Scores From the 14-item Mediterranean Diet Questionnaire

In order to assess adherence to the diet, we will report scores from the 14-item Mediterranean Diet questionnaire at 8 weeks. Scores range from 0 to 14 points. A higher score indicates greater adherence to the Mediterranean Diet.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Mediterranean DietScores From the 14-item Mediterranean Diet Questionnaire6.5 units on a scaleStandard Deviation 2.6
Usual CareScores From the 14-item Mediterranean Diet Questionnaire5.2 units on a scaleStandard Deviation 3
Primary

The Number of Patients Who Enrolled Completed the Study.

To assess feasibility of the study, we will report what percentage of patients who enrolled completed the study.

Time frame: 8 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Mediterranean DietThe Number of Patients Who Enrolled Completed the Study.23 Participants
Usual CareThe Number of Patients Who Enrolled Completed the Study.10 Participants
Secondary

The Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire

Fatigue will be measured using the Functional Assessment of Chronic Illness-Fatigue (FACIT-F). This is a 40-item questionnaire in which a higher score indicates greater well-being. Scores range from 0-160.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Mediterranean DietThe Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire114.1 units on a scaleStandard Deviation 28.4
Usual CareThe Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire116.9 units on a scaleStandard Deviation 20.4
Secondary

The Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire, Fatigue Subscale

Fatigue will be measured using the Functional Assessment of Chronic Illness-Fatigue (FACIT-F), fatigue subscale. This is a 13-item subscale of the FACIT-F questionnaire in which a higher score indicates less fatigue. Scores range from 0-52.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Mediterranean DietThe Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire, Fatigue Subscale35.3 units on a scaleStandard Deviation 12.1
Usual CareThe Functional Assessment of Chronic Illness-Fatigue (FACIT-F) Questionnaire, Fatigue Subscale36.0 units on a scaleStandard Deviation 9.8

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026